Pay in 4 interest-free payments of $5.26 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Alizadeh SD, et al
The first incretin-based drug approved specifically for weight loss was liraglutide (Saxenda), developed by Novo Nordisk
Dosage errors have led to symptoms such as nausea, vomiting, abdominal pain, and fainting, the agency said in a July 26 statement
Science 330 , 362366 (2010) Jung, S
It is particularly valuable for researchers studying the interplay between glucagon signaling, hepatic lipid oxidation, and thermogenesis -- areas where single- and dual-agonists provide limited data
RMID:Image ID:3D5ND8T Image details Contributor: Sipa USA Image ID: 3D5ND8T File size: 30.5 MB (567.7 KB Compressed download) Releases: Model - no | Property - noDo I need a release
US$ 21.61
US$ 25.77
US$ 27.48
US$ 20.53
US$ 20.83
